FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2077041132> ?p ?o ?g. }

• W2077041132 endingPage "S135" @default.
• W2077041132 startingPage "S131" @default.
• W2077041132 abstract "Exocrine pancreatic cancer is significantly more common in younger men than in younger women. The male-to-female sex ratio is, in most countries, between 1.25 and 1.75 to 1, but decreases with increasing age. Moreover, prior oophorectomy appeared in one study to be significantly more common in women with pancreatic cancer than in controls. This has raised interest in sex hormones in the development in pancreatic cancer. It has been questioned if there are estrogen receptors in ductal pancreatic cancer, but there are no doubt estrogen receptors and estrogen-binding protein in human healthy pancreas. It is also well proven that it is possible to influence experimental pancreatic cancer with estrogens. However, in clinical studies tamoxifen has repeatedly been shown to be without significant effects. On the other hand, there are also androgen receptors in pancreatic cancer and testosterone has been shown to strongly promote growth in experimental pancreatic cancers. It is therefore of considerable interest that an antiandrogen recently was shown to significantly prolong life in patients with unresectable pancreatic carcinoma. However, in patients with advanced pancreatic carcinoma the S-testosterone is low, far lower than what could be expected due to weight-loss and malnourishment alone. Pancreatic cancer has etiologically been connected to diet, for example the intake of fat. Cholecystokinin receptors have been found on human pancreatic cancer, possible to stimulate in vitro by cholecystokinin (CCK). Studies with CCK-receptor binding, hybridization with radiolabeled complementary DNA (cDNA) probes, or reverse-transcription polymerase chain reaction have shown that CCK-A receptors also are present in rat pancreatic putative preneoplastic lesions and cancer tissue, rat pancreatic-cancer cell lines, pancreatic carcinomas in transgenic mice, hamster pancreatic cancer, and human pancreatic cancer cell lines and tumors. Also, CCK-B receptors have been found in some human pancreatic cancers. There are a vast number of experiments done on CCK-stimulation of pancreatic cancer. They indicate that CCK may have a promotional effect on exocrine pancreatic cancer, but it is not probable that hyperstimulation with CCK alone induce pancreatic cancer. At present, however, despite a lot of evidence for a hormone-dependence of pancreatic cancer there are no data confirming a role for estrogens, androgens, CCK or their antagonists in clinical treatment of exocrine pancreatic cancer." @default.
• W2077041132 created "2016-06-24" @default.
• W2077041132 creator A5009375605 @default.
• W2077041132 creator A5035375827 @default.
• W2077041132 creator A5047474769 @default.
• W2077041132 date "1999-01-01" @default.
• W2077041132 modified "2023-10-16" @default.
• W2077041132 title "Other risk factors for pancreatic cancer: Hormonal aspects" @default.
• W2077041132 cites W1505019195 @default.
• W2077041132 cites W1951862875 @default.
• W2077041132 cites W1974902304 @default.
• W2077041132 cites W1978332441 @default.
• W2077041132 cites W1984396386 @default.
• W2077041132 cites W1987051809 @default.
• W2077041132 cites W1988749057 @default.
• W2077041132 cites W1988805463 @default.
• W2077041132 cites W1988945660 @default.
• W2077041132 cites W1990675136 @default.
• W2077041132 cites W1990875264 @default.
• W2077041132 cites W1991127909 @default.
• W2077041132 cites W1995390965 @default.
• W2077041132 cites W1995469518 @default.
• W2077041132 cites W1996743278 @default.
• W2077041132 cites W2000424284 @default.
• W2077041132 cites W2003908112 @default.
• W2077041132 cites W2005340528 @default.
• W2077041132 cites W2010643413 @default.
• W2077041132 cites W2032422975 @default.
• W2077041132 cites W2032793929 @default.
• W2077041132 cites W2033656475 @default.
• W2077041132 cites W2034155854 @default.
• W2077041132 cites W2046975101 @default.
• W2077041132 cites W2049725808 @default.
• W2077041132 cites W2052234996 @default.
• W2077041132 cites W2056786704 @default.
• W2077041132 cites W2058181817 @default.
• W2077041132 cites W2063755994 @default.
• W2077041132 cites W2067730689 @default.
• W2077041132 cites W2072116132 @default.
• W2077041132 cites W2076661664 @default.
• W2077041132 cites W2078341695 @default.
• W2077041132 cites W2083939213 @default.
• W2077041132 cites W2138250997 @default.
• W2077041132 cites W2148279982 @default.
• W2077041132 cites W2316493702 @default.
• W2077041132 cites W2401831084 @default.
• W2077041132 cites W4301631638 @default.
• W2077041132 doi "https://doi.org/10.1093/annonc/10.suppl_4.s131" @default.
• W2077041132 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10436805" @default.
• W2077041132 hasPublicationYear "1999" @default.
• W2077041132 type Work @default.
• W2077041132 sameAs 2077041132 @default.
• W2077041132 citedByCount "50" @default.
• W2077041132 countsByYear W20770411322012 @default.
• W2077041132 countsByYear W20770411322013 @default.
• W2077041132 countsByYear W20770411322014 @default.
• W2077041132 countsByYear W20770411322015 @default.
• W2077041132 countsByYear W20770411322016 @default.
• W2077041132 countsByYear W20770411322017 @default.
• W2077041132 countsByYear W20770411322018 @default.
• W2077041132 countsByYear W20770411322019 @default.
• W2077041132 countsByYear W20770411322020 @default.
• W2077041132 countsByYear W20770411322022 @default.
• W2077041132 countsByYear W20770411322023 @default.
• W2077041132 crossrefType "journal-article" @default.
• W2077041132 hasAuthorship W2077041132A5009375605 @default.
• W2077041132 hasAuthorship W2077041132A5035375827 @default.
• W2077041132 hasAuthorship W2077041132A5047474769 @default.
• W2077041132 hasBestOaLocation W20770411321 @default.
• W2077041132 hasConcept C121608353 @default.
• W2077041132 hasConcept C126322002 @default.
• W2077041132 hasConcept C134018914 @default.
• W2077041132 hasConcept C15660099 @default.
• W2077041132 hasConcept C170493617 @default.
• W2077041132 hasConcept C2777164284 @default.
• W2077041132 hasConcept C2777176818 @default.
• W2077041132 hasConcept C2777593968 @default.
• W2077041132 hasConcept C2777911890 @default.
• W2077041132 hasConcept C2778764654 @default.
• W2077041132 hasConcept C2780210213 @default.
• W2077041132 hasConcept C502942594 @default.
• W2077041132 hasConcept C530470458 @default.
• W2077041132 hasConcept C71315377 @default.
• W2077041132 hasConcept C71924100 @default.
• W2077041132 hasConcept C84606932 @default.
• W2077041132 hasConceptScore W2077041132C121608353 @default.
• W2077041132 hasConceptScore W2077041132C126322002 @default.
• W2077041132 hasConceptScore W2077041132C134018914 @default.
• W2077041132 hasConceptScore W2077041132C15660099 @default.
• W2077041132 hasConceptScore W2077041132C170493617 @default.
• W2077041132 hasConceptScore W2077041132C2777164284 @default.
• W2077041132 hasConceptScore W2077041132C2777176818 @default.
• W2077041132 hasConceptScore W2077041132C2777593968 @default.
• W2077041132 hasConceptScore W2077041132C2777911890 @default.
• W2077041132 hasConceptScore W2077041132C2778764654 @default.
• W2077041132 hasConceptScore W2077041132C2780210213 @default.
• W2077041132 hasConceptScore W2077041132C502942594 @default.
• W2077041132 hasConceptScore W2077041132C530470458 @default.

• next